Shockwave Medical Revenue and Competitors

Claim your profile

Location

$147.5M

Total Funding

Estimated Revenue & Valuation

  • Shockwave Medical's estimated annual revenue is currently $175.7M per year.(i)
  • Shockwave Medical received $35.0M in venture funding in October 2017.
  • Shockwave Medical's estimated revenue per employee is $246,050
  • Shockwave Medical's total funding is $147.5M.
  • Shockwave Medical's current valuation is $5.9B. (January 2022)

Employee Data

  • Shockwave Medical has 714 Employees.(i)
  • Shockwave Medical grew their employee count by 50% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M78-4%N/AN/A
#2
$3.5M34-8%N/AN/A
#3
$5.5M2283%N/AN/A
#4
$3.3M320%N/AN/A
#5
$5.8M23-28%N/AN/A
#6
$49.7M198-13%N/AN/A
#7
$9.8M39N/AN/AN/A
#8
$27.4M10911%N/AN/A
#9
$49.3M15728%$199.1MN/A
#10
$4.5M4416%N/AN/A

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians existing workflow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL ISI- bit.ly/2x9TiR4

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$147.5M

Total Funding

714

Number of Employees

$175.7M

Revenue (est)

50%

Employee Growth %

$5.9B

Valuation

N/A

Accelerator

Shockwave Medical News

2022-04-17 - ShockWave Medical, Inc. (NASDAQ:SWAV) VP Trinh Phung ...

ShockWave Medical, Inc, a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the...

2022-04-17 - ShockWave Medical, Inc. (NASDAQ:SWAV) Director Sells ...

ShockWave Medical, Inc, a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the...

2022-03-30 - Shockwave Medical Announces Global Launch of New ...

Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through...

2019-09-04 - FDA grants Shockwave Medical breakthrough device label

Shockwave Medical (NSDQ:SWAV) has won breakthrough device designation from the FDA for the sonic pressure-wave system it has developed to treat calcified coronary lesions. The Santa Clara, Calif.-based company’s C2 IVL (intravascular lithotripsy) catheter is designed to improve blood flow to th ...

2017-10-10 - Shockwave Medical Raises $35M in New Financing

Shockwave Medical, a Fremont, Calif.-based developer of a treatment of calcified cardiovascular disease, raised $35m in financing. This was an extension of the company’s previously announced $45m Series C financing. New investor Fidelity Management & Research Company participated, along with ce ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$290.7M716N/AN/A
#2
$147.8M728N/AN/A
#3
$332.2M730N/AN/A
#4
$149.8M73835%N/A
#5
$146.6M75140%N/A

Shockwave Medical Funding

DateAmountRoundLead InvestorsReference
2015-05-22$40.0MUndisclosedSofinnova PartnersArticle
2016-11-23$45.0MCSectoral Asset ManagementArticle
2017-10-11$35.0MCFidelity Management & Research CompanyArticle